Harvest Group Wealth Management, LLC Abb Vie Inc. Transaction History

Harvest Group Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $29,564 - $32,547	-289 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $8,934 - $10,486	-104 Reduced 26.46%	289 $25,000
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $1,687 - $2,258	-23 Reduced 5.53%	393 $38,000
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $1,290 - $1,955	20 Added 5.05%	416 $31,000
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $2,308 - $2,888	-32 Reduced 7.48%	396 $35,000
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $1,448 - $1,741	23 Added 5.68%	428 $32,000
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $13,140 - $16,796	-200 Reduced 33.06%	405 $29,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $46,669 - $54,927	605 New	605 $49,000

3,695

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.